Safety and efficacy of monotherapy change to fixed combination (travoprost 0.004%/timolol 0.5%) in 6 months follow up period.

1department of ophthalmology, Clinical department of Ophthalmology hospital Sisters of Charity, refferal Center for glaucoma, ministry of health and welfare of republic of Croatia, Zagreb; 2department of Ophthalmology, Clinical hospital Center Split, Split; 3department of Ophthalmology, Clinical hospital Center Zagreb, Zagreb; 4department of Ophthalmology, general hospital holy Spirit, Zagreb; 5department of Ophthalmology, Clinical hospital Center rijeka, rijeka; 6department of Ophthalmology, Clinical hospital Osijek, Osijek; 7department of Ophthalmology, Clinical hospital dubrava, Zagreb; 8department of Ophthalmology, general hospital Sibenik, Sibenik; 9department of Ophthalmology, Clinic for diabetes vuk vrhovac, Zagreb; 10 department of Ophthalmology, general hospital Zadar, Zadar